Recordings 29 Feb 2024 Webinar: Export controls and sanctions In the labyrinth of laws, regulations and sanctions, the international distribution of goods is a real challenge. What is the purpose of export c...
S-GE Event Tough price negotiations with "Lopez buyers" / Price Increase and Price Defense 25 Set 2024–26 Set 2024 Zurigo Svizzera
Fact-Finding Mission PropTech Tour to Berlin and Frankfurt 02 Set 2024–04 Set 2024 Berlin & Frankfurt Germania
Expertise 12 Dic 2022 EEN: a support network for SMEs seeking partnerships throughout Europe and beyond With negotiations on the future of Swiss-EU relations at a standstill, Swiss SMEs need – now more than ever – to find partnerships to help grow t...
Event S-GE Gut zu wissen: Expansion Schweizer PropTechs nach Deutschland und Österreich 10 Mag 2023 11:00–14:00 Zürich Svizzera
Fact-Finding Mission Switzerland goes NRW - Fact Finding Mission for Swiss Start-ups & Scale-ups to North Rhine-Westphalia/Germany 20 Giu 2023–21 Giu 2023 Germania
Fact Sheet 30 Ago 2022 EU Directives RoHS and WEEE: This is what Swiss firms need to know The EU directives RoHS II (2011/65/EU) and WEEE (2012/19/EU) of the European Commission restrict the usage of hazardous substances in electr...
Event S-GE Wirtschaftslunch Entsendung nach Deutschland und Österreich 27 Giu 2022 11:30–14:00 Luzern Svizzera
Webinar Cross-border e-commerce in Europe GOGLOBAL DAYS 2020 11 Set 2020 09:00–10:00 Online (CET/MEZ) Svizzera
Actualités 08 Mar 2021 Debiopharm signe un contrat de plus de EUR 900 millions avec Merck Debiopharm a accordé une licence mondiale exclusive au géant pharmaceutique Merck pour le développement et la commercialisation de son médicament...
Webinar-Aufzeichnungen 04 Mag 2022 Entwicklung der Energieeffizienz in Europa Was ändert sich in Österreich und Deutschland? Wie beeinflusst es Ihre Internationalisierung? Erhalten Sie einen Überblick über die Änderungen in...
News 08 Mar 2021 Debiopharm enters EUR 900+ million contract with Merck Debiopharm has granted a worldwide exclusive license to pharma giant Merck for the development and commercialization of its Xevinapant head and n...